CRISPR/Cas9 was used to insert extra copies of the beta-defensin 2 gene into pigs, producing higher peptide levels in all tissues with improved bacterial killing ability.
All tissues enhancedCRISPR-inserted beta-defensin 2 genes increased antimicrobial peptide production across every tissue tested
What the researchers found
Two copies of the pbd-2 gene linked by a T2A sequence were inserted into the porcine Rosa26 locus (a safe harbor site) using CRISPR/Cas9. The neomycin resistance marker was removed by cell-penetrating Cre recombinase with 48.3% efficiency, creating marker-free cells.
Cloned piglets were produced via somatic cell nuclear transfer. PCR and Southern blot confirmed correct gene insertion. Immunohistochemistry and immunofluorescence showed significantly higher PBD-2 protein across different tissues of transgenic piglets compared to wild-type littermates.
Functional testing was critical: cell culture supernatants from transgenic pig ear fibroblasts killed bacteria significantly more effectively than wild-type controls, confirming the extra PBD-2 is biologically active.
Why it matters
Pig farming loses billions annually to infectious disease. Porcine beta-defensin 2 has antimicrobial, immunomodulatory, and growth-promoting properties. Creating pigs that naturally produce more of this defense peptide could reduce antibiotic use in agriculture, a major driver of antibiotic resistance.
The numbers in context
2 pbd-2 copies; Rosa26 locus; 48.3% Cre efficiency; higher PBD-2 in all tissues; enhanced bactericidal activity
How the study worked
Genetic engineering study. CRISPR/Cas9 was used for targeted gene knock-in at the Rosa26 locus. Cre/loxP system removed the selection marker. Somatic cell nuclear transfer produced cloned piglets. Gene integration confirmed by PCR and Southern blot. Protein expression measured by immunohistochemistry and immunofluorescence. Antimicrobial function tested by bactericidal assays on cell culture supernatants.
Who was studied
CRISPR-edited cloned piglets (transgenic vs wild-type)
What this study cannot tell us
Small number of cloned piglets produced. Long-term health, growth performance, and actual disease resistance in farm conditions were not tested. Somatic cell nuclear transfer has high failure rates and ethical concerns. Regulatory approval for gene-edited food animals varies by country. The specific bacteria used in the bactericidal assay were not named in the abstract.
How to read the evidence
Preliminary evidence. Proof of concept achieved but long-term health, production, and disease resistance data needed.
When this study was published
Published in 2020. Gene-edited livestock research continues to advance alongside evolving regulatory frameworks.
The bigger picture
Pig farming loses billions annually to infectious disease. Creating pigs with enhanced antimicrobial peptide production could reduce antibiotic use in agriculture, addressing both animal welfare and the antibiotic resistance crisis.
Questions still open
- Do the gene-edited pigs have better disease resistance in real farm conditions?
- Are there any unintended health effects from constitutive PBD-2 overexpression?
- Would consumers and regulators accept gene-edited livestock?
Common questions
Why add more defensin genes to pigs?
Is this different from GMO?
Read the original research
Generation of Marker-Free pbd-2 Knock-in Pigs Using the CRISPR/Cas9 and Cre/loxP Systems.
Genes, 11(8)
Citation
Huang, Jing; Wang, Antian; Huang, Chao; Sun, Yufan; Song, Bingxiao; Zhou, Rui; Li, Lu. (2020). Generation of Marker-Free pbd-2 Knock-in Pigs Using the CRISPR/Cas9 and Cre/loxP Systems.. Genes, 11(8). https://doi.org/10.3390/genes11080951